| Literature DB >> 21245809 |
Nathalya I de Melo1, Lizandra G Magalhaes, Carlos E de Carvalho, Kamila A L Wakabayashi, Gabriela de P Aguiar, Rafael C Ramos, Andre L L Mantovani, Izabel C C Turatti, Vanderlei Rodrigues, Milton Groppo, Wilson R Cunha, Rodrigo C S Veneziani, Antônio E M Crotti.
Abstract
The in vitro schistosomicidal effects of the essential oil of Ageratum conyzoides L. (Ac-EO) against adult worms of Schistosoma mansoni is reported in this paper. Concerning this activity, Ac-EO was considered to be active, but less effective than the positive control (praziquantel, PZQ) in terms of separation of coupled pairs, mortality, decrease in motor activity, and tegumental alterations. However, Ac-EO caused an interesting dose-dependent reduction in the number of eggs of S. mansoni. Precocene I (74.30%) and (E)-caryophyllene (14.23%) were identified as the two major constituents of Ac-EO. These compounds were tested individually and were found to be much less effective than Ac-EO and PZQ. A mixture of the two major compounds in a ratio similar to that found in the Ac-EO was also less effective than Ac-EO, thus revealing that there are no synergistic effects between these components. These results suggest that the essential oil of A. conyzoides is very promising for the development of new schistosomicidal agents.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21245809 PMCID: PMC6259589 DOI: 10.3390/molecules16010762
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
In vitro effects of Ac-EO against S. mansoni adult worms.
| Group | Incubation period (h) | Number of separated worms (%) | Number of dead worms (%) | Decrease in motor activity | Number of worms with tegumental alteration | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Slight (%) | Significant (%) | Partial (%) | Extensive (%) | |||||||||
| M | F | M | F | M | F | M | F | M | F | |||
| Controla | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| DMSO 1%b | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| PZQc | 24 | 0 | 100 | 100 | 0 | 0 | 100 | 100 | 25 | 25 | 50 | 50 |
| 10 μg/mL | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 50 μg/mL | 24 | 50 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 50 | 25 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 100 μg/mL | 24 | 50 | 25 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 |
| 120 | 75 | 100 | 75 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | |
a,b Negative control groups (a RPMI 1640; b DMSO + RPMI medium); c Positive control at 10 μg/mL. M: males; F: females.
Figure 1In vitro effects of Ac-EO on the viability of S. mansoni adult worms. Pairs of adult worms were treated with Ac-EO at different concentrations, for 120 h, and the viability was measured by MTT assay at 550 nm. RPMI 1640 medium and 1% DMSO + RPMI 1640 medium were used as negative controls. Praziquantel (PZQ, 10 μg/mL) and heat-killed worms at 56 °C were used as positive control groups. Data are presented as the mean of four experiments. *** P < 0.001.
Figure 2In vitro effects of the Ac-EO on egg development. Quantitative analysis of the development of the phenotype. After treatment, the eggs were microscopically examined and scored as developed or undeveloped on the basis of the presence or absence of the miracidium. Data are presented as the mean of developed eggs from three separate experiments. ** P < 0.01.
Chemical constituents of the essential oil of A. conyzoides identified by GC-MS.
| Compound | Retention time (min) | Retention index | Peak area (%) |
|---|---|---|---|
| α-Thujene | 4.909 | 924 | 0.16 |
| α-Pinene | 5.100 | 931 | 0.30 |
| β-Cubebene | 22.312 | 1384 | 0.62 |
| β-Elemene | 22.396 | 1386 | 0.42 |
| ( | 23.594 | 1414 | 14.23 |
| α-Humulene | 25.059 | 1450 | 2.80 |
| Precocene I | 25.517 | 1461 | 74.30 |
| γ-Muurolene | 26.129 | 1476 | 3.44 |
| Germacrene D | 26.546 | 1486 | 0.59 |
| Bicyclogermacrene | 26.702 | 1490 | 3.14 |
Figure 4Chemical structures of precocene I (1) and (E)-caryophyllene (2).
In vitro effects of Precocene I (1), (E)-caryophyllene (2), and the 1 + 2 (4:1 w/w) mixture against S. mansoni adult worms.
| Group | Incubation period (h) | Number of separated worms (%) | Number of dead worms (%) | Decrease in motor activity | Number of worms with tegumental alteration | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Slight (%) | Significant (%) | Partial (%) | Extensive (%) | |||||||||
| M | F | M | F | M | F | M | F | M | F | |||
| Controla | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| PZQ b 10 μM | 24 | 0 | 100 | 100 | 0 | 0 | 100 | 100 | 25 | 25 | 50 | 50 |
| (3.1 μg/mL) | ||||||||||||
| ( | 24 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| (4.7 mg/mL) | 120 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (9.4 mg/mL) | 120 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| (18.8 mg/mL) | 120 | 0 | 0 | 0 | 75 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 50 | 0 | 0 | 75 | 75 | 0 | 0 | 0 | 0 | 0 | 0 |
| (37.6 mg/mL) | 120 | 50 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| (5.2 mg/mL) | 120 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| (10.4 mg/mL) | 120 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 50 | 75 | 0 | 0 | 0 | 0 | 0 | 0 |
| (20.8 mg/mL) | 120 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (41.6 mg/mL) | 120 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| ( | 24 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | |
| ( | 24 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | |
| ( | 24 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | |
| ( | 24 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| 120 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | |
a RPMI 1640. M: males; F: females.